Adalvo Ltd. S.C. Labormed-Pharma S.A.
PolandAll drugs from this manufacturer
-
Rivaxar is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (in the case of acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 2.5 mg ATC: B01AF01
-
The medicine is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery, and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg ATC: B01AF01
-
The medicine is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels (in atrial fibrillation). It is also used to treat deep vein thrombosis in the legs and pulmonary embolism, as well as to prevent the recurrence of these clots.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg ATC: B01AF01
-
The medicine is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels (e.g., in atrial fibrillation) and to treat and prevent the recurrence of thrombosis in the veins of the legs and in the blood vessels of the lungs.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg ATC: B01AF01